Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Asana Inc is a software-application business based in the US. Asana shares (ASAN) are listed on the NYSE and all prices are listed in US Dollars. Asana employs 1,080 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Experienced Investors
Our top pick for
Large Accounts
| Latest market close | $127.65 |
|---|---|
| 52-week range | $20.57 - $124.85 |
| 50-day moving average | $104.68 |
| 200-day moving average | $64.47 |
| Wall St. target price | $89.91 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.74 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $127.65 from 2021-10-19
| 1 week (2021-10-14) | 9.82% |
|---|---|
| 1 month (2021-09-21) | 12.19% |
| 3 months (2021-07-21) | 83.17% |
| 6 months (2021-04-21) | 301.16% |
| 1 year (2020-10-20) | 429.67% |
|---|---|
| 2 years (2019-10-17) | N/A |
| 3 years (2018-10-17) | N/A |
| 5 years (2016-10-17) | N/A |
| Revenue TTM | $293.4 million |
|---|---|
| Gross profit TTM | $198.3 million |
| Return on assets TTM | -19.85% |
| Return on equity TTM | -147.32% |
| Profit margin | -89.91% |
| Book value | $1.52 |
| Market capitalisation | $21.4 billion |
TTM: trailing 12 months
There are currently 5.0 million Asana shares held short by investors – that's known as Asana's "short interest". This figure is 3.8% up from 4.9 million last month.
There are a few different ways that this level of interest in shorting Asana shares can be evaluated.
Asana's "short interest ratio" (SIR) is the quantity of Asana shares currently shorted divided by the average quantity of Asana shares traded daily (recently around 3.7 million). Asana's SIR currently stands at 1.37. In other words for every 100,000 Asana shares traded daily on the market, roughly 1370 shares are currently held short.
However Asana's short interest can also be evaluated against the total number of Asana shares, or, against the total number of tradable Asana shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Asana's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Asana shares in existence, roughly 30 shares are currently held short) or 0.0622% of the tradable shares (for every 100,000 tradable Asana shares, roughly 62 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Asana.
Find out more about how you can short Asana stock.
We're not expecting Asana to pay a dividend over the next 12 months.
Asana, Inc. , together with its subsidiaries, operates a work management platform for individuals, team leads, and executives in the United States and internationally. It provides a work management platform as software as service that enables individuals and teams to get work done faster while enhancing employee engagement by allowing everyone to see how their work connects to the mission of an organization. The company was formerly known as Smiley Abstractions, Inc. and changed its name to Asana, Inc. in July 2009. Asana, Inc.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
